Maze Therapeutics, Inc. (MAZE) Insider Trading
Over the last 3 months, MAZE insiders made 0 open-market buys and 17 sales, a net sale of -$4.2M (SEC Form 4). Over the last 6 months, 59 institutions increased and 37 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
17
Net (3m)
-$4.2M
Insider trades by month Buys Sells
Mar
Apr
May
Jun
Jul
Aug
Context3-month price +2.9%Institutions reducing (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 31, 2026 | Dandekar Atulofficer: CSBO | Sell | 7,500 | $27.58 |
| Aug 31, 2026 | Dandekar Atulofficer: CSBO | Option | 7,500 | $10.42 |
| Aug 17, 2026 | Kornowski Sophiedirector | Grant | 36,000 | $27.66 |
| Aug 17, 2026 | Johnson Paula Adirector | Grant | 36,000 | $27.66 |
| Aug 14, 2026 | Bernstein Haroldofficer: President, R&D & CMO | Option | 16,142 | $10.42 |
| Aug 14, 2026 | Bernstein Haroldofficer: President, R&D & CMO | Sell | 16,142 | $27.61 |
| Aug 5, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 30,304 | $26.71 |
| Aug 5, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 2,439 | $26.71 |
| Aug 5, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 154 | $27.09 |
| Aug 5, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 1,604 | $27.09 |
| Jul 31, 2026 | Dandekar Atulofficer: CSBO | Sell | 7,100 | $27.31 |
| Jul 31, 2026 | Dandekar Atulofficer: CSBO | Sell | 400 | $27.89 |
| Jul 31, 2026 | Dandekar Atulofficer: CSBO | Option | 7,500 | $10.42 |
| Jul 2, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 2,593 | $29.98 |
| Jul 2, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 1,597 | $30.44 |
| Jul 2, 2026 | Bernstein Haroldofficer: President, R&D & CMO | Option | 14,609 | $10.42 |
| Jul 2, 2026 | Bernstein Haroldofficer: President, R&D & CMO | Sell | 13,409 | $29.86 |
| Jul 2, 2026 | Bernstein Haroldofficer: President, R&D & CMO | Sell | 1,200 | $30.34 |
| Jul 2, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 30,311 | $29.95 |
| Jul 1, 2026 | Dandekar Atulofficer: CSBO | Option | 7,500 | $10.42 |
| Jul 1, 2026 | Dandekar Atulofficer: CSBO | Sell | 7,500 | $28.02 |
| Jun 24, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 2,040 | $26.00 |
| Jun 24, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 1,953 | $26.00 |
| Jun 24, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 23,865 | $26.05 |
| Jun 10, 2026 | Andrews Nancy Cdirector | Grant | 18,000 | $23.58 |
| Jun 10, 2026 | HOMCY CHARLES Jdirector | Grant | 18,000 | $23.58 |
| Jun 10, 2026 | Hoppenot Hervedirector | Grant | 18,000 | $23.58 |
| Jun 10, 2026 | Lim Jonathan Edirector | Grant | 18,000 | $23.58 |
| Jun 10, 2026 | SCHELLER RICHARD Hdirector | Grant | 18,000 | $23.58 |
| Jun 10, 2026 | SPIEGELMAN DANIEL Kdirector | Grant | 18,000 | $23.58 |
Source: MAZE SEC Form 4 filings, latest Aug 31, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their MAZE positions over the last 6 months (SEC Form 13F).
Increased
59
New positions
54
Reduced
37
Sold out
166
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | Unchanged | 4.6M | May 15, 2026 |
| TRV GP IV, LLC | Unchanged | 4.5M | May 7, 2026 |
| ARCH VENTURE MANAGEMENT, LLC | Unchanged | 4.1M | May 15, 2026 |
| DEEP TRACK CAPITAL, LP | Reduced | 3.5M | May 15, 2026 |
| JANUS HENDERSON GROUP PLC | Reduced | 2.9M | May 18, 2026 |
| PARADIGM BIOCAPITAL ADVISORS LP | New Position | 2.7M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 2.6M | May 13, 2026 |
| AH CAPITAL MANAGEMENT, L.L.C. | Unchanged | 1.7M | May 15, 2026 |
| VR ADVISER, LLC | Increased | 1.6M | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1.4M | May 15, 2026 |
| ALPHABET INC. | Unchanged | 1.4M | May 8, 2026 |
| LOGOS GLOBAL MANAGEMENT LP | Increased | 1.2M | May 15, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | New Position | 1.2M | May 15, 2026 |
| GENERAL CATALYST GROUP MANAGEMENT, LLC | Unchanged | 1.0M | May 15, 2026 |
| TRV GP V, LLC | Unchanged | 951K | May 7, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.